EstechPharma Co. Ltd (041910) - Cash Flow Conversion Efficiency
Based on the latest financial reports, EstechPharma Co. Ltd (041910) has a cash flow conversion efficiency ratio of 0.018x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩2.38 Billion ≈ $1.61 Million USD) by net assets (₩135.93 Billion ≈ $92.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check EstechPharma Co. Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
EstechPharma Co. Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how EstechPharma Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. See 041910 total equity for net asset value and shareholders' equity analysis.
EstechPharma Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of EstechPharma Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Daelim B&Co
KO:005750
|
-0.002x |
|
International Conveyors Limited
NSE:INTLCONV
|
-0.016x |
|
Apollo Minerals Ltd
AU:AON
|
-0.137x |
|
Camus Engineering & Construction Inc
KO:013700
|
0.037x |
|
LondonMetric Property Plc
LSE:LMP
|
0.025x |
|
GP Global Power Ltd
TA:GPGB
|
-0.052x |
|
Hwacheon Mac
KO:000850
|
0.007x |
|
Moberg Pharma AB (publ)
ST:MOB
|
0.002x |
Annual Cash Flow Conversion Efficiency for EstechPharma Co. Ltd (2013–2025)
The table below shows the annual cash flow conversion efficiency of EstechPharma Co. Ltd from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see 041910 stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩135.93 Billion ≈ $92.12 Million |
₩8.83 Billion ≈ $5.99 Million |
0.065x | +5.33% |
| 2024-12-31 | ₩128.58 Billion ≈ $87.14 Million |
₩7.93 Billion ≈ $5.38 Million |
0.062x | +48.95% |
| 2023-12-31 | ₩115.63 Billion ≈ $78.36 Million |
₩4.79 Billion ≈ $3.25 Million |
0.041x | +391.41% |
| 2022-12-31 | ₩116.09 Billion ≈ $78.67 Million |
₩-1.65 Billion ≈ $-1.12 Million |
-0.014x | -390.39% |
| 2021-12-31 | ₩123.30 Billion ≈ $83.56 Million |
₩603.42 Million ≈ $408.93K |
0.005x | -88.42% |
| 2020-12-31 | ₩111.39 Billion ≈ $75.49 Million |
₩4.71 Billion ≈ $3.19 Million |
0.042x | +1.21% |
| 2019-12-31 | ₩102.72 Billion ≈ $69.61 Million |
₩4.29 Billion ≈ $2.91 Million |
0.042x | -48.58% |
| 2018-12-31 | ₩89.25 Billion ≈ $60.48 Million |
₩7.25 Billion ≈ $4.91 Million |
0.081x | -4.26% |
| 2017-12-31 | ₩82.38 Billion ≈ $55.83 Million |
₩6.99 Billion ≈ $4.74 Million |
0.085x | -19.76% |
| 2016-12-31 | ₩77.42 Billion ≈ $52.47 Million |
₩8.19 Billion ≈ $5.55 Million |
0.106x | -27.10% |
| 2015-12-31 | ₩72.13 Billion ≈ $48.88 Million |
₩10.46 Billion ≈ $7.09 Million |
0.145x | +120.71% |
| 2014-12-31 | ₩75.99 Billion ≈ $51.50 Million |
₩4.99 Billion ≈ $3.38 Million |
0.066x | -56.18% |
| 2013-12-31 | ₩67.96 Billion ≈ $46.05 Million |
₩10.19 Billion ≈ $6.91 Million |
0.150x | -- |
About EstechPharma Co. Ltd
EstechPharma Co., Ltd. manufactures and sells pharmaceuticals products. It also offers raw materials, such as RBM and PLK. The company was formerly known as Estech Chemical and changed its name to EstechPharma Co., Ltd. in January 2001. EstechPharma Co., Ltd. was founded in 1996 and is headquartered in Hwaseong-si, South Korea.